These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9708418)

  • 1. Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers.
    Sculpher MJ; Gibb D; Ades AE; Ratcliffe J; Duong T
    AIDS; 1998 Jul; 12(11):1371-80. PubMed ID: 9708418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and benefits to the mother of antenatal HIV testing: estimates from simulation modelling.
    Gibb DM; Ades AE; Gupta R; Sculpher MJ
    AIDS; 1999 Aug; 13(12):1569-76. PubMed ID: 10465082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness.
    Ratcliffe J; Ades AE; Gibb D; Sculpher MJ; Briggs AH
    AIDS; 1998 Jul; 12(11):1381-8. PubMed ID: 9708419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financing HIV service provision in England: estimated impact of the cost of antiretroviral combination therapy.
    Beck EJ; Tolley K
    Int J STD AIDS; 1998 Sep; 9(9):512-7. PubMed ID: 9764934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing cost of English HIV service provision 1996-1997. NPMS Steering Group. National Prospective Monitoring System.
    Int J STD AIDS; 1999 Jun; 10(6):357-62. PubMed ID: 10414877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect cost of HIV infection in England.
    Mullins CD; Whitelaw G; Cooke JL; Beck EJ
    Clin Ther; 2000 Nov; 22(11):1333-45. PubMed ID: 11117658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the cost of getting the price wrong?
    Beck EJ; Beecham J; Mandalia S; Griffith R; Walters MD; Boulton M; Miller DL
    J Public Health Med; 1999 Sep; 21(3):311-7. PubMed ID: 10528959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost effectiveness of universal antenatal screening for HIV in New Zealand.
    Bramley D; Graves N; Walker D
    AIDS; 2003 Mar; 17(5):741-8. PubMed ID: 12646798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
    Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong.
    Lee PM; Wong KH
    Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of expanded antenatal HIV testing in London.
    Postma MJ; Beck EJ; Hankins CA; Mandalia S; Jager JC; de Jong-van den Berg LT; Walters MD; Sherr L
    AIDS; 2000 Oct; 14(15):2383-9. PubMed ID: 11089627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
    Sante; 1999; 9(5):277-81. PubMed ID: 10657769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric AIDS and perinatal HIV infection in Zaire: epidemiologic and pathologic findings.
    Nelson AM; Firpo A; Kamenga M; Davachi F; Angritt P; Mullick FG
    Prog AIDS Pathol; 1992; 3(1):1-33. PubMed ID: 1606299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of HIV screening for incarcerated pregnant women.
    Resch S; Altice FL; Paltiel AD
    J Acquir Immune Defic Syndr; 2005 Feb; 38(2):163-73. PubMed ID: 15671801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
    Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
    N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia.
    Graves N; Walker DG; McDonald AM; Kaldor JM; Ziegler JB
    J Infect Dis; 2004 Jul; 190(1):166-74. PubMed ID: 15195257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.
    Udeh B; Udeh C; Graves N
    BMC Infect Dis; 2008 Dec; 8():174. PubMed ID: 19117527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of preventing AIDS-related opportunistic infections.
    Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
    JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.